Bal Pharma Ltd - Share Price
BALPHARMA
Bal Pharma LtdFinancials
Bal Pharma LtdNews & Updates
Bal Pharma launches Favipiravir under brand 'BALflu' in Indian market; Stock hits 5% upper circuit
May 25,2021 02:19 PM
Favipiravir an emerging antiviral drug, is used for patients with mild to moderate Covid-19 infection.
Shailesh Siroya acquires 6.5 lakh equity shares of Bal Pharma under preferential issue Mar 23,2021
ICRA revises Bal Pharma's long term fund facilities outlook to 'stable', reaffirms rating Mar 16,2021
No pains, only gains! Crompton Greaves, Bal Pharma, 68 others hit 52-week high Dec 02,2015
Bal Pharma hits 10% upper limit Dec 02,2015
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 673.20 | 72.47 | 161,523.23 | 327.39 | 1.11 | 3,119.04 | 104.36 |
| Divis Laboratories Ltd | 4,313.05 | 58.58 | 114,493.94 | 487.93 | 0.46 | 1,718.39 | 349.25 |
| Dr Reddys Laboratories Ltd | 5,410.85 | 41.20 | 90,073.89 | 311.50 | 0.46 | 3,313.50 | 1,020.99 |
| Cipla Ltd | 969.70 | 31.68 | 78,197.60 | 413.41 | 0.52 | 3,173.39 | 247.09 |
| Cadila Healthcare Ltd | 646.00 | 40.60 | 66,164.48 | 464.70 | 0.54 | 1,949.70 | 124.49 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Bal Pharma LtdSummary & Reports
No Company Summary found
Registered Office
21 & 22 Bommasandra Indl Area,Hosur Road,Bangalore, Karnataka,560092
Tell. : +
Website : http://www.balpharma.com
Email : secretarial@balpharma.com/info@balpharma.com
Registrar Office
C-101 1st Floor, Lal Bahadur Marg, Mumbai - 400 083 INDIA
Tell. : +
Website : www.tsrdarashaw.com
Email : csg-unit@tsrdarashaw.com
Reports by bal-pharma-ltd-share-price
Latest Release by bal-pharma-ltd-share-price
Result Express
Shareholding Snapshot
Loading ...
| Mar - 2021 | |
|---|---|
| Promoter | - |
| Foreign | 4.42% |
| Indian | 40.56% |
| Total Promoter | 44.98% |
| Non Promoter | - |
| Institutions | 0.00% |
| Non-Institutions | 55.02% |
| Total Non-Promoter | 55.02% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Board Meeting
Exp. Date
17 Mar 2021
Annc. Date
09 Mar 2021
BAL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is schedul... More
Purpose
Board Meeting
Exp. Date
11 Feb 2021
Annc. Date
20 Jan 2021
BAL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is schedul... More
